stoxline Quote Chart Rank Option Currency Glossary
  
Veradigm Inc. (MDRX)
10.75  0.1 (0.94%)    12-09 15:00
Open: 10.95
High: 11
Volume: 118,271
  
Pre. Close: 10.65
Low: 10.65
Market Cap: 1,157(M)
Technical analysis
2024-12-09 4:47:57 PM
Short term     
Mid term     
Targets 6-month :  13.78 1-year :  16.09
Resists First :  11.8 Second :  13.78
Pivot price 10.6
Supports First :  10 Second :  8.89
MAs MA(5) :  10.67 MA(20) :  10.69
MA(100) :  9.76 MA(250) :  9.13
MACD MACD :  0.2 Signal :  0.2
%K %D K(14,3) :  42.7 D(3) :  42.6
RSI RSI(14): 54.7
52-week High :  11.8 Low :  5.01
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ MDRX ] has closed below upper band by 44.5%. Bollinger Bands are 3.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 11.02 - 11.07 11.07 - 11.12
Low: 10.52 - 10.58 10.58 - 10.63
Close: 10.57 - 10.66 10.66 - 10.73
Company Description

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Headline News

Mon, 09 Dec 2024
Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX) - Business Wire

Tue, 03 Dec 2024
Veradigm Inc (MDRX) Stock Surges Amidst Financial Report Insights - GuruFocus.com

Tue, 03 Dec 2024
Veradigm (NASDAQ:MDRX) Now Covered by StockNews.com - MarketBeat

Mon, 25 Nov 2024
Veradigm (NASDAQ:MDRX) Coverage Initiated by Analysts at StockNews.com - MarketBeat

Thu, 21 Nov 2024
Veradigm Launches AI-Powered Medical Scribe Platform to Transform Healthcare Documentation - StockTitan

Tue, 19 Nov 2024
Veradigm Expands Healthcare Platform Integration with Insiteflow, Adds Epic EHR Support | MDRX Stock News - StockTitan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
OTC
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Shares Out 108 (M)
Shares Float 108 (M)
Held by Insiders 1.1 (%)
Held by Institutions 17.2 (%)
Shares Short 8,130 (K)
Shares Short P.Month 9,430 (K)
Stock Financials
EPS 0.86
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 10.77
Profit Margin 3.9 %
Operating Margin 16.5 %
Return on Assets (ttm) 2.1 %
Return on Equity (ttm) 8.9 %
Qtrly Rev. Growth 5 %
Gross Profit (p.s.) 0
Sales Per Share 14.21
EBITDA (p.s.) 1.07
Qtrly Earnings Growth -1.8 %
Operating Cash Flow 161 (M)
Levered Free Cash Flow 156 (M)
Stock Valuations
PE Ratio 12.38
PEG Ratio -0.7
Price to Book value 0.98
Price to Sales 0.74
Price to Cash Flow 7.12
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android